Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

A Reference System for BRCA Mutation Detection Based on Next-Generation Sequencing in the Chinese Population.

Qu S, Chen Q, Yi Y, Shao K, Zhang W, Wang Y, Bai J, Li X, Liu Z, Wang X, Jing R, Guan Y, Yi X, Yan M, Cao B, Chen F, Zhu S, Yang X, Wu Y, Huang J.

J Mol Diagn. 2019 Jul;21(4):677-686. doi: 10.1016/j.jmoldx.2019.03.003. Epub 2019 Apr 23.

PMID:
31026599
2.

Genotyping of Circulating Tumor DNA Reveals the Clinically Actionable Mutation Landscape of Advanced Colorectal Cancer.

Cao W, Xu Y, Chang L, Gong Y, Li L, Mo X, Zhang X, Lin G, Zhou J, Liu D, Yi Y, Dai P, Zhu C, Liu T, Chu Y, Guan Y, Chen Y, Wang J, Xia X, Yang L, Yi X, Cheng Y.

Mol Cancer Ther. 2019 Jun;18(6):1158-1167. doi: 10.1158/1535-7163.MCT-18-1247. Epub 2019 Apr 23.

PMID:
31015309
3.

Prevalence of recurrent oncogenic fusion in mismatch repair-deficient colorectal carcinoma with hypermethylated MLH1 and wild-type BRAF and KRAS.

Wang J, Yi Y, Xiao Y, Dong L, Liang L, Teng L, Ying JM, Lu T, Liu Y, Guan Y, Pang J, Zhou L, Lu J, Zhang Z, Liu X, Liang X, Zeng X, Yi X, Zhou W, Xia X, Yang L, Zhang J, Kopetz S, Futreal PA, Wu H, Liang Z.

Mod Pathol. 2019 Feb 5. doi: 10.1038/s41379-019-0212-1. [Epub ahead of print]

PMID:
30723297
4.

Author Correction: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer.

Nong J, Gong Y, Guan Y, Yi X, Yi Y, Chang L, Yang L, Lv J, Guo Z, Jia H, Chu Y, Liu T, Chen M, Byers L, Roarty E, Lam VK, Papadimitrakopoulou VA, Wistuba I, Heymach JV, Glisson B, Liao Z, Lee JJ, Futreal PA, Zhang S, Xia X, Zhang J, Wang J.

Nat Commun. 2019 Jan 29;10(1):552. doi: 10.1038/s41467-019-08570-x.

5.

Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients.

Huang Y, Wang LA, Xie Q, Pang J, Wang L, Yi Y, Zhang J, Zhang Y, Chen R, Lan W, Zhang D, Jiang J.

Endocr Connect. 2018 Dec 1;7(12):1217-1225. doi: 10.1530/EC-18-0325.

6.

Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer.

Nong J, Gong Y, Guan Y, Yi X, Yi Y, Chang L, Yang L, Lv J, Guo Z, Jia H, Chu Y, Liu T, Chen M, Byers L, Roarty E, Lam VK, Papadimitrakopoulou VA, Wistuba I, Heymach JV, Glisson B, Liao Z, Lee JJ, Futreal PA, Zhang S, Xia X, Zhang J, Wang J.

Nat Commun. 2018 Aug 6;9(1):3114. doi: 10.1038/s41467-018-05327-w. Erratum in: Nat Commun. 2019 Jan 29;10(1):552.

7.

A retrospective case study of sunitinib treatment in three patients with Von Hippel-Lindau disease.

Yuan G, Liu Q, Tong D, Liu G, Yi Y, Zhang J, Zhang Y, Wang LA, Wang L, Chen R, Guan Y, Yi X, Lan W, Jiang J.

Cancer Biol Ther. 2018;19(9):766-772. doi: 10.1080/15384047.2018.1470732. Epub 2018 Jul 9.

8.

Novel genotype-phenotype correlations in five Chinese families with Von Hippel-Lindau disease.

Liu Q, Yuan G, Tong D, Liu G, Yi Y, Zhang J, Zhang Y, Wang LA, Wang L, Zhang D, Chen R, Guan Y, Yi X, Lan W, Jiang J.

Endocr Connect. 2018 Jul;7(7):870-878. doi: 10.1530/EC-18-0167. Epub 2018 Jun 5.

9.

A novel germline ARMC5 mutation in a patient with bilateral macronodular adrenal hyperplasia: a case report.

Liu Q, Tong D, Xu J, Yang X, Yi Y, Zhang D, Wang L, Zhang J, Zhang Y, Li Y, Chang L, Chen R, Guan Y, Yi X, Jiang J.

BMC Med Genet. 2018 Mar 27;19(1):49. doi: 10.1186/s12881-018-0564-2.

10.

A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapy.

Liu Q, Tong D, Liu G, Yi Y, Xu J, Yang X, Wang L, Zhang J, Ye J, Zhang Y, Yuan G, Wang P, Chen R, Guan Y, Yi X, Zhang D, Jiang J.

Cancer Biol Ther. 2018 Aug 3;19(8):669-675. doi: 10.1080/15384047.2018.1451278. Epub 2018 Apr 19.

11.

Carney complex with PRKAR1A gene mutation: A case report and literature review.

Liu Q, Tong D, Liu G, Yi Y, Zhang D, Zhang J, Zhang Y, Huang Z, Li Y, Chen R, Guan Y, Yi X, Jiang J.

Medicine (Baltimore). 2017 Dec;96(50):e8999. doi: 10.1097/MD.0000000000008999. Review.

12.

Selection, purification, and characterization of a HER2-targeting soluble designed ankyrin repeat protein by E. coli surface display using HER2-positive melanoma cells.

Chen X, Yu X, Song X, Liu L, Yi Y, Yao W, Gao X.

Prep Biochem Biotechnol. 2018 Feb 7;48(2):144-150. doi: 10.1080/10826068.2017.1407944. Epub 2018 Feb 9.

PMID:
29313422
13.

HIF2A germline-mutation-induced polycythemia in a patient with VHL-associated renal-cell carcinoma.

Liu Q, Tong D, Liu G, Yi Y, Zhang D, Zhang J, Zhang Y, Huang Z, Li Y, Chen R, Guan Y, Yi X, Jiang J.

Cancer Biol Ther. 2017 Dec 2;18(12):944-947. doi: 10.1080/15384047.2017.1394553. Epub 2017 Nov 27. Erratum in: Cancer Biol Ther. 2018 Feb 1;19(2):139.

14.

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing.

Lv X, Zhao M, Yi Y, Zhang L, Guan Y, Liu T, Yang L, Chen R, Ma J, Yi X.

J Vis Exp. 2017 Aug 24;(126). doi: 10.3791/56342.

PMID:
28872127
15.

Targeted next-generation sequencing identification of mutations in patients with disorders of sex development.

Dong Y, Yi Y, Yao H, Yang Z, Hu H, Liu J, Gao C, Zhang M, Zhou L, Asan, Yi X, Liang Z.

BMC Med Genet. 2016 Mar 15;17:23. doi: 10.1186/s12881-016-0286-2.

16.

Comprehensive carrier genetic test using next-generation deoxyribonucleic acid sequencing in infertile couples wishing to conceive through assisted reproductive technology.

Martin J, Asan, Yi Y, Alberola T, Rodríguez-Iglesias B, Jiménez-Almazán J, Li Q, Du H, Alama P, Ruiz A, Bosch E, Garrido N, Simon C.

Fertil Steril. 2015 Nov;104(5):1286-93. doi: 10.1016/j.fertnstert.2015.07.1166. Epub 2015 Sep 3.

PMID:
26354092
17.

Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing.

Guan Y, Hu H, Peng Y, Gong Y, Yi Y, Shao L, Liu T, Li G, Wang R, Dai P, Bignon YJ, Xiao Z, Yang L, Mu F, Xiao L, Xie Z, Yan W, Xu N, Zhou D, Yi X.

Fam Cancer. 2015 Mar;14(1):9-18. doi: 10.1007/s10689-014-9749-9.

PMID:
25151137
18.

Targeted high-throughput sequencing identifies pathogenic mutations in KCNQ4 in two large Chinese families with autosomal dominant hearing loss.

Wang H, Zhao Y, Yi Y, Gao Y, Liu Q, Wang D, Li Q, Lan L, Li N, Guan J, Yin Z, Han B, Zhao F, Zong L, Xiong W, Yu L, Song L, Yi X, Yang L, Petit C, Wang Q.

PLoS One. 2014 Aug 12;9(8):e103133. doi: 10.1371/journal.pone.0103133. eCollection 2014.

19.

Heat shock protein 90 inhibitor mycoepoxydiene modulates kinase signaling in cervical cancer cells and inhibits in-vivo tumor growth.

Lin P, Yi Y, Lu M, Wang M, Yang Y, Lu Y, Song S, Zheng Z, Deng X, Zhang L.

Anticancer Drugs. 2015 Jan;26(1):25-34. doi: 10.1097/CAD.0000000000000135.

PMID:
25014191
20.

Newborn hearing concurrent genetic screening for hearing impairment-a clinical practice in 58,397 neonates in Tianjin, China.

Zhang J, Wang P, Han B, Ding Y, Pan L, Zou J, Liu H, Pang X, Liu E, Wang H, Liu H, Zhang X, Cheng X, Feng D, Li Q, Wang D, Zong L, Yi Y, Tian N, Mu F, Tian G, Chen Y, Liu G, Zhang F, Yi X, Yang L, Wang Q.

Int J Pediatr Otorhinolaryngol. 2013 Dec;77(12):1929-35. doi: 10.1016/j.ijporl.2013.08.038. Epub 2013 Sep 8.

PMID:
24100002
21.

Mycoepoxydiene, a fungal polyketide inhibits MCF-7 cells through simultaneously targeting p53 and NF-κB pathways.

Wang J, Zhao B, Yi Y, Zhang W, Wu X, Zhang L, Shen Y.

Biochem Pharmacol. 2012 Oct 1;84(7):891-9. doi: 10.1016/j.bcp.2012.07.004. Epub 2012 Jul 14.

PMID:
22796259
22.

Hsp90 interacts with AMPK and mediates acetyl-CoA carboxylase phosphorylation.

Zhang L, Yi Y, Guo Q, Sun Y, Ma S, Xiao S, Geng J, Zheng Z, Song S.

Cell Signal. 2012 Apr;24(4):859-65. doi: 10.1016/j.cellsig.2011.12.001. Epub 2011 Dec 13.

PMID:
22178220
23.

Gambogic acid inhibits Hsp90 and deregulates TNF-α/NF-κB in HeLa cells.

Zhang L, Yi Y, Chen J, Sun Y, Guo Q, Zheng Z, Song S.

Biochem Biophys Res Commun. 2010 Dec 17;403(3-4):282-7. doi: 10.1016/j.bbrc.2010.11.018. Epub 2010 Nov 11.

PMID:
21074517

Supplemental Content

Loading ...
Support Center